Moderna shares soar amid positive cancer vaccine trials
Moderna’s CEO said the company’s experimental melanoma vaccine could be available by 2025. The company’s shares reacted with...
Moderna’s CEO said the company’s experimental melanoma vaccine could be available by 2025. The company’s shares reacted with...